14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 15, 2024 Buy 6 577 Auerbach Alan H Common Stock
Mar 15, 2024 Buy 9 047 Auerbach Alan H Stock Option (Right to Buy)
Feb 12, 2024 Buy 43 307 Wong Alvin F Common Stock
Feb 12, 2024 Buy 59 946 Wong Alvin F Stock Option (Right to Buy)
Feb 12, 2024 Buy 43 307 Nougues Maximo F Common Stock
Feb 12, 2024 Buy 59 946 Nougues Maximo F Stock Option (Right to Buy)
Feb 12, 2024 Buy 27 067 Ludwig Jeffrey Jerome Common Stock
Feb 12, 2024 Buy 37 466 Ludwig Jeffrey Jerome Stock Option (Right to Buy)
Feb 12, 2024 Buy 160 796 Auerbach Alan H Common Stock
Feb 12, 2024 Buy 222 573 Auerbach Alan H Stock Option (Right to Buy)
Feb 12, 2024 Buy 37 894 Hunt Douglas M Common Stock
Feb 12, 2024 Buy 52 452 Hunt Douglas M Stock Option (Right to Buy)
Jan 03, 2024 Sell 7 733 Wong Alvin F Common Stock
Jan 03, 2024 Sell 12 956 Ludwig Jeffrey Jerome Common Stock
Jan 03, 2024 Sell 41 396 Auerbach Alan H Common Stock
Jan 03, 2024 Sell 15 682 Nougues Maximo F Common Stock
Jan 03, 2024 Sell 8 358 Hunt Douglas M Common Stock
Dec 04, 2023 Sell 280 Wong Alvin F Common Stock
Nov 07, 2023 Sell 25 000 Miller Michael Patrick Common Stock
Jul 03, 2023 Sell 6 938 Wong Alvin F Common Stock
Jul 03, 2023 Sell 14 680 Nougues Maximo F Common Stock
Jul 03, 2023 Sell 12 103 Ludwig Jeffrey Jerome Common Stock
Jul 03, 2023 Sell 7 809 Hunt Douglas M Common Stock
Jul 03, 2023 Sell 60 698 Auerbach Alan H Common Stock
Jun 13, 2023 Buy 27 000 Wilson Troy Edward Common Stock
Jun 13, 2023 Sell 27 000 Wilson Troy Edward Common Stock
Jun 13, 2023 Buy 27 000 Moyes Jay M Common Stock
Jun 13, 2023 Sell 22 000 Moyes Jay M Common Stock
Jun 13, 2023 Buy 27 000 Stuglik Brian M Common Stock
Jun 13, 2023 Sell 9 900 Stuglik Brian M Common Stock
Jun 13, 2023 Buy 27 000 Senderowicz Adrian Common Stock
Jun 13, 2023 Sell 27 000 Senderowicz Adrian Common Stock
Jun 13, 2023 Buy 27 000 Dorval Allison Common Stock
Jun 13, 2023 Sell 10 000 Dorval Allison Common Stock
Jun 13, 2023 Buy 27 000 Miller Michael Patrick Common Stock
Jun 13, 2023 Sell 13 500 Miller Michael Patrick Common Stock
Jun 13, 2023 Buy 27 000 Cesano Alessandra Common Stock
Jun 02, 2023 Sell 269 Wong Alvin F Common Stock
Feb 10, 2023 Buy 58 601 Wong Alvin F Common Stock
Feb 10, 2023 Buy 81 399 Wong Alvin F Stock Option (Right to Buy)
Feb 10, 2023 Buy 58 601 Nougues Maximo F Common Stock
Feb 10, 2023 Buy 81 399 Nougues Maximo F Stock Option (Right to Buy)
Feb 10, 2023 Buy 66 972 Ludwig Jeffrey Jerome Common Stock
Feb 10, 2023 Buy 93 028 Ludwig Jeffrey Jerome Stock Option (Right to Buy)
Feb 10, 2023 Buy 48 136 Hunt Douglas M Common Stock
Feb 10, 2023 Buy 66 864 Hunt Douglas M Stock Option (Right to Buy)
Feb 10, 2023 Buy 186 403 Auerbach Alan H Common Stock
Feb 10, 2023 Buy 258 924 Auerbach Alan H Stock Option (Right to Buy)
Jan 03, 2023 Sell 3 460 Wong Alvin F Common Stock
Jan 03, 2023 Sell 10 499 Nougues Maximo F Common Stock
Jan 03, 2023 Sell 6 568 Ludwig Jeffrey Jerome Common Stock
Jan 03, 2023 Sell 4 225 Hunt Douglas M Common Stock
Jan 03, 2023 Sell 27 241 Auerbach Alan H Common Stock
Dec 12, 2022 Buy 568 181 Auerbach Alan H Common Stock
Dec 02, 2022 Sell 1 251 Auerbach Alan H Common Stock
Dec 02, 2022 Sell 429 Hunt Douglas M Common Stock
Dec 02, 2022 Sell 159 Nougues Maximo F Common Stock
Dec 02, 2022 Sell 514 Wong Alvin F Common Stock
Nov 02, 2022 Sell 429 Hunt Douglas M Common Stock
Nov 02, 2022 Sell 1 242 Auerbach Alan H Common Stock
Nov 02, 2022 Sell 163 Nougues Maximo F Common Stock
Oct 03, 2022 Sell 165 Nougues Maximo F Common Stock
Oct 03, 2022 Sell 435 Hunt Douglas M Common Stock
Oct 03, 2022 Sell 1 260 Auerbach Alan H Common Stock
Sep 02, 2022 Sell 164 Nougues Maximo F Common Stock
Sep 02, 2022 Sell 433 Hunt Douglas M Common Stock
Sep 02, 2022 Sell 1 254 Auerbach Alan H Common Stock
Aug 09, 2022 Sell 25 000 Miller Michael Patrick Common Stock
Aug 02, 2022 Sell 161 Nougues Maximo F Common Stock
Aug 02, 2022 Sell 429 Hunt Douglas M Common Stock
Aug 02, 2022 Sell 1 247 Auerbach Alan H Common Stock
Jul 29, 2022 Buy 100 000 Cesano Alessandra STOCK OPTION (RIGHT TO BUY)
Jul 29, 2022 Buy 100 000 Cesano Alessandra STOCK OPTION (RIGHT TO BUY)
Jul 29, 2022 Buy 0 Cesano Alessandra
Jul 05, 2022 Sell 9 328 Nougues Maximo F Common Stock
Jul 05, 2022 Sell 3 753 Hunt Douglas M Common Stock
Jul 05, 2022 Sell 26 140 Auerbach Alan H Common Stock
Jul 05, 2022 Sell 5 835 Nougues Maximo F Common Stock
Jul 05, 2022 Sell 5 835 Ludwig Jeffrey Jerome Common Stock
Jul 05, 2022 Sell 2 920 Wong Alvin F Common Stock
Jun 16, 2022 Sell 27 858 Senderowicz Adrian Common Stock
Jun 16, 2022 Sell 27 858 Wilson Troy Edward Common Stock
Jun 16, 2022 Sell 13 000 Stuglik Brian M Common Stock
Jun 16, 2022 Sell 22 858 Moyes Jay M Common Stock
Jun 14, 2022 Buy 27 000 Senderowicz Adrian Common Stock
Jun 14, 2022 Buy 27 000 Moyes Jay M Common Stock
Jun 14, 2022 Buy 27 000 Dorval Allison Common Stock
Jun 14, 2022 Buy 27 000 Stuglik Brian M Common Stock
Jun 14, 2022 Buy 27 000 Miller Michael Patrick Common Stock
Jun 14, 2022 Buy 27 000 Wilson Troy Edward Common Stock
Jun 02, 2022 Sell 587 Wong Alvin F Common Stock
Jun 02, 2022 Sell 162 Nougues Maximo F Common Stock
Jun 02, 2022 Sell 417 Hunt Douglas M Common Stock
Jun 02, 2022 Sell 1 200 Auerbach Alan H Common Stock
May 03, 2022 Sell 438 Hunt Douglas M Common Stock
May 03, 2022 Sell 165 Nougues Maximo F Common Stock
May 03, 2022 Sell 1 263 Auerbach Alan H Common Stock
Apr 04, 2022 Sell 1 198 Auerbach Alan H Common Stock
Apr 04, 2022 Sell 413 Hunt Douglas M Common Stock
Apr 04, 2022 Sell 206 Nougues Maximo F Common Stock
INSIDER POWER
64.723
Last 100 transactions
Buy: 2 879 886 | Sell: 561 464 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 64.723.

In total, the insiders bought 2 879 886 and sold 561 464 PBYI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Puma Biotechnology Inc

Puma Biotechnology Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance... PBYI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT